|Reason for decision
|Anticipate the topic will be of importance to patients, carers, professionals, commissioners and the health of the public to ensure clinical benefit is realised, inequalities in use addressed, and help them make the best use of NHS resources
|Low back pain is a common musculoskeletal (MSK) condition which affects a significant proportion of people in England. It is also a leading and long-standing cause of morbidity, in terms of years lived with disability. Low back pain increases in prevalence with age and has a negative impact on health and national productivity. The NHS Long Term Plan states that low back and neck pain is the greatest cause of years lost to disability, with chronic joint pain or osteoarthritis affecting over 8.75 million people in the UK. Low back pain is the leading cause of disability in the UK, attributable to 1,434.66 years lived with disability per 100,000 population. Majority of non-emergency Low back pain cases are managed in primary care, which has limited workforce capacity and resource to meet the needs of patients. There is an unmet need in terms of access to services which offer diagnosis and physical and psychological therapies for MSK-related pain, to support recovery, secondary prevention of pain episodes and return to work. This early value assessment focusses on the use of digital technologies for treating and managing low back pain. Digital technologies for low back pain can provide rapid access to specialist advice and guidance, remote pain management programmes including physical activity recommendations and psychological therapy via web-based applications and digital platforms. These technologies could reduce the number of GP visits, provide quicker virtual consultation, promote self-management, and improve psychological impact of pain.
- If you have any queries please email email@example.com
|08 December 2023
|Committee meeting: 2
|13 October 2023 - 25 October 2023
|22 September 2023
|Committee meeting: 1
|17 July 2023
|22 May 2023
|16 May 2023
For further information on our processes and methods, please see our early value assessment interim statement.